Life Sciences Intelligence June 21, 2024
Veronica Salib

The solution includes the VENTANA DP 200 slide scanner, a digital pathology workflow software, and a display for clinical diagnostics.

The United States FDA granted Roche 510(k) clearance for the Roche Digital Pathology DX, a whole-slide imaging digital pathology solution to aid in diagnostics. The system includes multiple components, such as the VENTANA DP 200 slide scanner, digital pathology workflow software, and a display.

An article in Cureus defines whole-slide imaging as a component of digital pathology that uses scanning technology to generate digital images of entire glass slides. Healthcare professionals can then use the digitized images of slides to observe cell and tissue structures and make diagnostic conclusions.

According to the company’s press release, the tool’s primary goal is...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Digital Health, FDA, Govt Agencies, Medical Devices, Technology
Related Articles:
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease
Trump's Picks for Top Health Jobs Not Just Team of Rivals but 'Team of Opponents'
FDA updates definition of 'healthy'
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

Share This Article